GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galmed Pharmaceuticals Ltd (FRA:GPH) » Definitions » Cyclically Adjusted FCF per Share

Galmed Pharmaceuticals (FRA:GPH) Cyclically Adjusted FCF per Share : €-148.56 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Galmed Pharmaceuticals Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Galmed Pharmaceuticals's adjusted free cash flow per share for the three months ended in Dec. 2024 was €-1.129. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-148.56 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-05-23), Galmed Pharmaceuticals's current stock price is €2.736. Galmed Pharmaceuticals's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 was €-148.56. Galmed Pharmaceuticals's Cyclically Adjusted Price-to-FCF of today is .


Galmed Pharmaceuticals Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Galmed Pharmaceuticals's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galmed Pharmaceuticals Cyclically Adjusted FCF per Share Chart

Galmed Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -142.13 -159.59 -148.56

Galmed Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -159.59 -155.98 -160.62 -71.92 -148.56

Competitive Comparison of Galmed Pharmaceuticals's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Galmed Pharmaceuticals's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galmed Pharmaceuticals's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galmed Pharmaceuticals's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Galmed Pharmaceuticals's Cyclically Adjusted Price-to-FCF falls into.


;
;

Galmed Pharmaceuticals Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Galmed Pharmaceuticals's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-1.129/133.1571*133.1571
=-1.129

Current CPI (Dec. 2024) = 133.1571.

Galmed Pharmaceuticals Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -33.661 99.621 -44.992
201506 -27.016 100.684 -35.729
201509 -32.581 100.392 -43.215
201512 -32.968 99.792 -43.991
201603 -44.726 100.470 -59.277
201606 -43.468 101.688 -56.920
201609 -46.210 101.861 -60.408
201612 -39.235 101.863 -51.289
201703 -53.368 102.862 -69.086
201706 -36.853 103.349 -47.482
201709 -35.217 104.136 -45.032
201712 -28.781 104.011 -36.846
201803 -35.138 105.290 -44.438
201806 -14.241 106.317 -17.836
201809 -14.138 106.507 -17.676
201812 -17.188 105.998 -21.592
201903 -28.940 107.251 -35.931
201906 -24.068 108.070 -29.655
201909 -30.060 108.329 -36.949
201912 -31.299 108.420 -38.440
202003 -50.525 108.902 -61.778
202006 -47.068 108.767 -57.622
202009 -40.339 109.815 -48.913
202012 -53.692 109.897 -65.056
202103 -60.008 111.754 -71.500
202106 -45.612 114.631 -52.983
202109 -54.957 115.734 -63.230
202112 -44.511 117.630 -50.387
202203 -35.612 121.301 -39.093
202206 -40.230 125.017 -42.850
202209 -22.464 125.227 -23.887
202212 -27.136 125.222 -28.856
202303 -11.227 127.348 -11.739
202306 -9.014 128.729 -9.324
202309 -47.442 129.860 -48.647
202312 -1.960 129.419 -2.017
202403 -3.701 131.776 -3.740
202406 -1.800 132.554 -1.808
202409 -13.899 133.029 -13.912
202412 -1.129 133.157 -1.129

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Galmed Pharmaceuticals  (FRA:GPH) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Galmed Pharmaceuticals Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Galmed Pharmaceuticals's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Galmed Pharmaceuticals Business Description

Traded in Other Exchanges
Address
16 Abba Hillel Road, Ramat Gan, ISR, 5250608
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Galmed Pharmaceuticals Headlines

No Headlines